Top Suppliers:I want be here
  • DC Chemicals Limited
  • China
  • Product Name: MC-1742
  • Price: $Inquiry/100mg $Inquiry/250mg $Inquiry/500mg
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao

1776116-74-5

1776116-74-5 structure
1776116-74-5 structure
  • Name: MC 1742
  • Chemical Name: MC1742
  • CAS Number: 1776116-74-5
  • Molecular Formula: C21H21N3O3S
  • Molecular Weight: 395.47
  • Catalog: Signaling Pathways Apoptosis Apoptosis
  • Create Date: 2021-01-15 02:27:48
  • Modify Date: 2024-01-09 12:31:27
  • MC1742 is a potent HDAC inhibitor, with IC50s of 0.1 μM, 0.11 μM, 0.02 μM, 0.007 μM, 0.61 μM, 0.04 μM and 0.1 μM for HDAC1, HDAC2, HDAC3, HDAC6, HDAC8, HDAC10 and HDAC11, respectively. MC1742 can increase acetyl-H3 and acetyl-tubulin levels and inhibits cancer stem cells growth. MC1742 can induce growth arrest, apoptosis, and differentiation in sarcoma CSC[1].

Name MC1742
Synonyms Pentanamide, 5-[(4-[1,1'-biphenyl]-4-yl-1,6-dihydro-6-oxo-2-pyrimidinyl)thio]-N-hydroxy-
MFCD30290158
MC1742
5-{[4-(4-Biphenylyl)-6-oxo-1,6-dihydro-2-pyrimidinyl]sulfanyl}-N-hydroxypentanamide
Description MC1742 is a potent HDAC inhibitor, with IC50s of 0.1 μM, 0.11 μM, 0.02 μM, 0.007 μM, 0.61 μM, 0.04 μM and 0.1 μM for HDAC1, HDAC2, HDAC3, HDAC6, HDAC8, HDAC10 and HDAC11, respectively. MC1742 can increase acetyl-H3 and acetyl-tubulin levels and inhibits cancer stem cells growth. MC1742 can induce growth arrest, apoptosis, and differentiation in sarcoma CSC[1].
Related Catalog
Target

HDAC1:0.1 μM (IC50)

HDAC2:0.11 μM (IC50)

HDAC3:0.02 μM (IC50)

HDAC6:0.007 μM (IC50)

HDAC8:0.61 μM (IC50)

HDAC10:0.04 μM (IC50)

HDAC11:0.1 μM (IC50)

In Vitro MC1742 (compound 1) (0.5 and 2 μM; 24 hours) increases acetylation in a dose-dependent manner, observable as punctuate nuclear staining of acetyl-histone H3[1]. MC1742 (0.5, 1 and 2 μM; 24, 48 and 72 hours) significantly induces apoptosis of all CSC cultures[1]. MC1742 (0.025-0.5 μM; 14 days) enhances bone nodule formation in a significant dose-dependent manner[1]. Immunofluorescence Cell Line: Sarcoma cancer stem cells[1] Concentration: 0.5 and 2 μM Incubation Time: 24 hours Result: Increased acetylation in a dose-dependent manner, observable as punctuate nuclear staining of acetyl-histone H3. Apoptosis Analysis Cell Line: Sarcoma cancer stem cells[1] Concentration: 0.5, 1 and 2 μM Incubation Time: 24, 48 and 72 hours Result: Significantly induced apoptosis of all CSC cultures. Cell Differentiation Assay Cell Line: Sarcoma cancer stem cells[1] Concentration: 0.025, 0.05, 0.1 and 0.5 μM Incubation Time: 14 days Result: Successfully enhanced bone nodule formation in a significant dose-dependent manner.
References

[1]. Di Pompo G, et al. Novel histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in sarcoma cancer stem cells. J Med Chem. 2015;58(9):4073-4079.

Density 1.3±0.1 g/cm3
Molecular Formula C21H21N3O3S
Molecular Weight 395.47
Exact Mass 395.130371
LogP 3.24
Index of Refraction 1.649